Juno Therapeutics Surges on Report of Celgene Deal Talks

(Bloomberg) -- Juno Therapeutics Inc. surged after the Wall Street Journal reported that Celgene Corp. was in talks to buy the Seattle-based drugmaker.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.